Herbst, Roy S.
Soria, Jean-Charles
Kowanetz, Marcin
Fine, Gregg D.
Hamid, Omid
Gordon, Michael S.
Sosman, Jeffery A.
McDermott, David F.
Powderly, John D.
Gettinger, Scott N.
Kohrt, Holbrook E. K.
Horn, Leora
Lawrence, Donald P.
Rost, Sandra
Leabman, Maya
Xiao, Yuanyuan
Mokatrin, Ahmad
Koeppen, Hartmut
Hegde, Priti S.
Mellman, Ira
Chen, Daniel S.
Hodi, F. Stephen
Article History
Received: 9 May 2014
Accepted: 31 October 2014
First Online: 26 November 2014
Change Date: 11 May 2015
Change Type: Correction
Change Details: A minor change was made to an amino acid in the Methods.
Competing interests
: R.S.H. is a consultant for and receives research funding from Genentech, Inc. O.H. is a speaker and consultant for, and receives research funding from, Genentech, Inc. F.S.H. works as a non-paid advisor to Genentech, Inc., Bristol-Myers Squibb and Merck; is a member of the Amgen advisory board; is a compensated advisor to Novartis; and received clinical trials support from Genentech, Inc., Bristol-Myers Squibb, Merck and Novartis. L.H. received research funding from Astellas; is a member of advisory boards for Bristol-Myers Squibb, Clovis and Helix BioPharma; provides uncompensated advice for PUMA and Xcovery; is an uncompensated member of Bayer’s steering committee; and received an honoraria from Boehringer Ingelheim. D.F.M. is a participant on advisory boards for Genentech, Inc. Bristol-Myers Squibb and Merck. J.D.P. is the Founder and CEO of Biologics Human Application Lab; worked as a consultant and/or advisor to Bristol-Myers Squibb, Genentech, Inc., Amplimmune and Merck; received honoraria from Bristol-Myers Squibb; received research funding from Bristol-Myers Squibb, Genentech, Inc., Amplimmune, Merck, AstraZeneca and ImClone Systems; and has participated in Bristol-Myers Squibb Speaker’s Bureau and advisory boards. J.-C.S. is a compensated advisory board participant for Genentech, Inc. M.K., G.D.F., S.R., M.L., Y.X., A.M., H.K., P.S.H., I.M. and D.S.C. are employees of Genentech, Inc. M.S.G., J.A.S., S.N.G., H.E.K.K. and D.P.L. have nothing to declare.
Free to read: This content has been made available to all.